2 weeks Ago By ABMN Staff
Clorox ( NYSE:CLX – Get Free Report ) had its price objective hoisted by research analysts at Citigroup from $145.00 to $165.00 in a research report issued on Wednesday, Benzinga reports.
The brokerage currently has a “neutral” rating on the stock. Citigroup’s target price would suggest a potential upside of 4.92% from the stock’s previous close.
Several other analysts have also issued reports on CLX. TD Cowen started coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.
00 target price for the company. Wells Fargo & Company decreased their price target on shares of Clorox from $135.00 to $130.
00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. DA Davidson decreased their price target on shares of Clorox from $162.00 to $153.
00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Argus raised shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Clorox from $144.
00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company.
Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $143.19. Read Our Latest Analysis on Clorox Clorox Stock Performance Clorox ( NYSE:CLX – Get Free Report ) last released its quarterly earnings results on Thursday, August 1st.
The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.
28. Clorox had a return on equity of 382.58% and a net margin of 3.
95%. The business had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.
97 billion. On average, equities research analysts expect that Clorox will post 6.4 earnings per share for the current fiscal year.
Institutional Trading of Clorox Several large investors have recently added to or reduced their stakes in CLX. International Assets Investment Management LLC boosted its holdings in Clorox by 3,665.3% in the fourth quarter.
International Assets Investment Management LLC now owns 102,718 shares of the company’s stock valued at $14,647,000 after acquiring an additional 99,990 shares in the last quarter. Choreo LLC boosted its holdings in shares of Clorox by 12.8% during the 4th quarter.
Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after buying an additional 652 shares in the last quarter. Certuity LLC bought a new stake in shares of Clorox during the 4th quarter valued at $442,000. Mission Wealth Management LP boosted its holdings in shares of Clorox by 6.
2% during the 4th quarter. Mission Wealth Management LP now owns 7,297 shares of the company’s stock valued at $1,040,000 after buying an additional 423 shares in the last quarter. Finally, MONECO Advisors LLC bought a new stake in shares of Clorox during the 4th quarter valued at $236,000.
Institutional investors own 78.53% of the company’s stock. Clorox Company Profile ( Get Free Report ) The Clorox Company manufactures and markets consumer and professional products worldwide.
It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. Recommended Stories Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.
com's FREE daily email newsletter ..
